NEW LIGNOSULFONATES AS NEXT GENERATION ANTIMICROBIALS

Mark Moloney Theme: Biocatalysis & Biotransformation, Downstream Processing, Sustainable Feedstock Cohort Year: 2017 Academic Partner: University of St Andrews Industry Partner: BluTest

Supervisor:Prof. Nick Westwood/ Prof. Alexandra M Slavin

I am undergoing a PhD in St Andrews focusing on the modification of lignin in an effort to develop antimicrobial compounds.  Lignin is a by-product of biofuels and so finding a commercial use for it would make greener fuel options more economically viable and cost-effective.  I will be working in BluTest in Glasgow to perform microbial screens of my developed compounds.  I received my B.A in Medicinal Chemistry from Trinity College Dublin, where I carried out a project developing compounds for S. aureus decolonisation.  I am very excited to further develop the skills I learned there in this PhD.